Related Experiment Video
Updated: Dec 6, 2025

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
8.6K
Inflatable penile prosthesis outcomes after pelvic radiation.
Chirag N Dave1, Taylor P Kohn, Hiten D Patel
1Johns Hopkins University School of Medicine, Brady Urological Institute, Baltimore, Maryland, USA.
The Canadian Journal of Urology
|October 13, 2020
Summary
Pelvic radiation therapy (RT) does not significantly increase surgical complication risks for inflatable penile prosthesis (IPP) patients. This study supports IPP use in men with a history of RT and erectile dysfunction.
Area of Science:
- Urology
- Andrology
- Surgical Oncology
Background:
- Few studies have evaluated surgical outcomes of 3-piece inflatable penile prosthesis (IPP) in patients previously treated with pelvic radiation therapy (RT).
- Understanding complication rates is crucial for managing erectile dysfunction (ED) in cancer survivors.
Purpose of the Study:
- To compare surgical outcomes and complication rates of 3-piece IPP placement in patients with and without a history of pelvic RT.
- To assess the safety and efficacy of IPP in men with refractory ED following pelvic RT.
Main Methods:
- Retrospective analysis of 715 patients undergoing 3-piece IPP implantation (2007-2018).
- Comparison between 101 patients with pelvic RT exposure and 153 radiation-naïve controls (history of radical prostatectomy only).
- Analysis of surgical complications, comorbidities, and patient characteristics.
Main Results:
- Patients exposed to RT had higher BMI and Charlson co-morbidity index scores.
- Surgical complication rate was 18.4% in the RT group versus 11.5% in the control group (not statistically significant, p=0.141).
- Multivariable analysis indicated RT exposure was not significantly associated with increased complication risk (OR: 1.31; CI 0.55-3.12).
Conclusions:
- This study demonstrates no significant increase in surgical complication risk following 3-piece IPP placement in patients with a history of pelvic RT.
- The findings support the use of IPP as a viable treatment option for men with refractory ED after pelvic RT.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
338
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
338
Radiological Investigation III: Pulmonary Angiogram and PET Scan
291
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
291

